1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-

1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- Struktur
2367004-54-2
CAS-Nr.
2367004-54-2
Englisch Name:
1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-
Synonyma:
XL-092;JUN04542;Zanzalintinib;XL092, 10 mM in DMSO;Zanzalintinib (XL-092);N-(4-Fluorophenyl)-N-(4-((7-methoxy-6-(methylcarbamoyl)quinolin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide;1-N'-(4-fluorophenyl)-1-N-[4-[7-methoxy-6-(methylcarbamoyl)quinolin-4-yl]oxyphenyl]cyclopropane-1,1-dicarboxamide;1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-;Axl,c-Met/HGFR,Vascular endothelial growth factor receptor,p-MET,XL092,TAM Receptor,p-VEGFR2,Mer,ATP,XL 092,VEGFR,Inhibitor,Tyro3,XL-092,orally,inhibit
CBNumber:
CB98845693
Summenformel:
C29H25FN4O5
Molgewicht:
528.53
MOL-Datei:
2367004-54-2.mol

1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- Eigenschaften

Siedepunkt:
840.4±65.0 °C(Predicted)
Dichte
1.408±0.06 g/cm3(Predicted)
storage temp. 
4°C, protect from light
Löslichkeit
DMSO : 25 mg/mL (47.30 mM; Need ultrasonic)
pka
13.14±0.46(Predicted)
Aggregatzustand
Solid
Farbe
Off-white to light brown
InChIKey
JSPCKALGNNVYOO-UHFFFAOYSA-N
SMILES
C1(C(NC2=CC=C(OC3C4C(N=CC=3)=CC(OC)=C(C(NC)=O)C=4)C=C2)=O)(C(NC2=CC=C(F)C=C2)=O)CC1

Sicherheit

1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden

1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 57)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 33024 60
TargetMol Chemicals Inc.
+1-781-999-5354; +17819995354
marketing@targetmol.com United States 32435 58
Shenzhen Shengda Pharma Limited
755-85269922 +8613424394241
sales@shengdapharm.com CHINA 310 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6391 58
TargetMol Chemicals Inc.
+1-781-999-5354;
support@targetmol.com United States 39035 58
Beijing Sunsoly S&T Co.,Ltd
+8613910445483
amanda@sunsoly.com China 264 58
Wuhan Jingkang en Biomedical Technology Co., Ltd
+8613720134139
orders@jknbiochem.com China 5221 58
Chongqing jooe co., ltd
+undefined86-15223382610
info@jooe.com China 6208 58
Taizhou Nanfeng Pharmaceutical Research Institute nanfengdrug@163.com; 18616377689
nanfengdrug@163.com China 20009 58
Chongqing Chemieliva Pharmaceutical Co., Ltd. 18696571988
amy.lei@chemieliva.com China 1554 60

2367004-54-2()Verwandte Suche:


  • 1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-
  • XL-092
  • JUN04542
  • Zanzalintinib
  • Axl,c-Met/HGFR,Vascular endothelial growth factor receptor,p-MET,XL092,TAM Receptor,p-VEGFR2,Mer,ATP,XL 092,VEGFR,Inhibitor,Tyro3,XL-092,orally,inhibit
  • N-(4-Fluorophenyl)-N-(4-((7-methoxy-6-(methylcarbamoyl)quinolin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide
  • Zanzalintinib (XL-092)
  • XL092, 10 mM in DMSO
  • 1-N'-(4-fluorophenyl)-1-N-[4-[7-methoxy-6-(methylcarbamoyl)quinolin-4-yl]oxyphenyl]cyclopropane-1,1-dicarboxamide
  • 2367004-54-2
Copyright 2019 © ChemicalBook. All rights reserved